A Study Investigating agenT-797 in Participants With Relapsed/Refractory Solid Tumors
Clinical trial NCT05108623 · COMPLETED
Trial details
- NCT number
- NCT05108623
- Sponsor
- MiNK Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-28
- Primary completion
- 2024-01-02
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.